horizontal
sciextext
text-left
Understanding and quantifying the charge heterogeneity profile of a biotherapeutic is necessary for setting specifications to demonstrate process robustness and to support regulatory findings.
Join the discussion in this webinar and probe the cause of color change in a protein therapeutic. Learn how a cell line development group is utilizing the integrated icIEF-UV/MS workflow to monitor these events for product release.
Presented by:
Kristen Nields, PhD
Senior Scientist
Cell Engineering and Analytical Sciences
J&J Innovative Medicines